Alchornea laxiflora as therapeutic agent in the treatment of Trypanosoma brucei brucei infection using experimental wistar rats; invivo and gene expression studies

Catherine Olusunmibola Durojaye; Olusola Olalekan Elekofehinti; Innocent Bamidele Osho; Stephen Olusola Abodunrin

doi:10.5455/JRVS.20230812093455

2024, Vol: 2, Issue: 3

2 / 3Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

« Previous Article

Research Article

Online Publishing Date:
02 / 09 / 2023

J Res Vet Sci. 2023; 1(1): 27-36

doi: 10.5455/JRVS.20230812093455

Alchornea laxiflora as therapeutic agent in the treatment of Trypanosoma brucei brucei infection using experimental wistar rats; invivo and gene expression studies

Catherine Olusunmibola Durojaye, Olusola Olalekan Elekofehinti, Innocent Bamidele Osho, Stephen Olusola Abodunrin.

Abstract
Aims: African trypanosomosis is a zoonotic tropical disease of Sub-Saharan Africa. Its etiology is a group of extracellular protozoans of the genera Trypanosoma which has numerous species including Trypanosoma brucei brucei. Inavailability of vaccines and numerous side effects arising from few available antitrypanosomal drugs gives the indication for search for local alternatives. This experimental study investigates the antitrypanosomal efficacy of chloroform extract of A. laxiflora leaves in wistar albino rats infected with Trypanosoma brucei brucei.

Place and Duration of Study: Animal Parasitology and Microbiology Research Unit, Department of Animal Production and Health, Federal University of Technology, Akure, Nigeria, between July and November, 2022.

Methodology: Thirty-six rats of both sexes were infected with Trypanosoma brucei brucei and treated with Alchornea laxiflora extracts intraperitoneally at dosages of 100, 200 and 400mg/kg for three consecutive days. Diminacene aceturate at 3.5mg/kg as single dose was used as positive control. Daily parasiteamia, rectal temperature and body weight were monitored for 26 days. Antioxidant (SOD, CAT, Nrf2) and pro-inflammatory (TNF-α, IL-6) gene expressions were determined.

Results: Treatment with Alchornea laxiflora caused significant (p < 0.05) decrease in parasitemia of infected rats compared to negative control. Increase in weight gain was recorded after the initial weight loss post infection. There was prolongation of survival days to 22days at 400mg/kg treatment dose compared to 7days in the untreated control. Significant (p < 0.05) dose dependent upward regulation of SOD, CAT and Nrf2 antioxidant genes and down-regulation of TNF-α and IL-6 inflammatory genes were observed in all treatment groups compared to the untreated control in the spleen and liver.

Conclusion: These observations suggest that A. laxiflora extract possess excellent anti-trypanosomal properties with the downregulation of pro inflammatory genes and up-regulation of antioxidant genes

Key words: Alchornea laxiflora. Antioxidant genes, invivo antitrypanosomal, proinfammatory genes, Trypanosomoma brucei brucei

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Catherine Olusunmibola Durojaye Articles by Olusola Olalekan Elekofehinti Articles by Innocent Bamidele Osho Articles by Stephen Olusola Abodunrin
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Durojaye CO, Elekofehinti OO, Osho IB, Abodunrin SO. Alchornea laxiflora as therapeutic agent in the treatment of Trypanosoma brucei brucei infection using experimental wistar rats; invivo and gene expression studies. J Res Vet Sci. 2023; 1(1): 27-36. doi:10.5455/JRVS.20230812093455

Web Style

Durojaye CO, Elekofehinti OO, Osho IB, Abodunrin SO. Alchornea laxiflora as therapeutic agent in the treatment of Trypanosoma brucei brucei infection using experimental wistar rats; invivo and gene expression studies. https://www.scopub.com/jrvs/?mno=165077 [Access: April 19, 2024]. doi:10.5455/JRVS.20230812093455

AMA (American Medical Association) Style

Durojaye CO, Elekofehinti OO, Osho IB, Abodunrin SO. Alchornea laxiflora as therapeutic agent in the treatment of Trypanosoma brucei brucei infection using experimental wistar rats; invivo and gene expression studies. J Res Vet Sci. 2023; 1(1): 27-36. doi:10.5455/JRVS.20230812093455

Vancouver/ICMJE Style

Durojaye CO, Elekofehinti OO, Osho IB, Abodunrin SO. Alchornea laxiflora as therapeutic agent in the treatment of Trypanosoma brucei brucei infection using experimental wistar rats; invivo and gene expression studies. J Res Vet Sci. (2023), [cited April 19, 2024]; 1(1): 27-36. doi:10.5455/JRVS.20230812093455

Harvard Style

Durojaye, C. O., Elekofehinti, . O. O., Osho, . I. B. & Abodunrin, . S. O. (2023) Alchornea laxiflora as therapeutic agent in the treatment of Trypanosoma brucei brucei infection using experimental wistar rats; invivo and gene expression studies. J Res Vet Sci, 1 (1), 27-36. doi:10.5455/JRVS.20230812093455

Turabian Style

Durojaye, Catherine Olusunmibola, Olusola Olalekan Elekofehinti, Innocent Bamidele Osho, and Stephen Olusola Abodunrin. 2023. Alchornea laxiflora as therapeutic agent in the treatment of Trypanosoma brucei brucei infection using experimental wistar rats; invivo and gene expression studies. Journal of Research in Veterinary Sciences, 1 (1), 27-36. doi:10.5455/JRVS.20230812093455

Chicago Style

Durojaye, Catherine Olusunmibola, Olusola Olalekan Elekofehinti, Innocent Bamidele Osho, and Stephen Olusola Abodunrin. "Alchornea laxiflora as therapeutic agent in the treatment of Trypanosoma brucei brucei infection using experimental wistar rats; invivo and gene expression studies." Journal of Research in Veterinary Sciences 1 (2023), 27-36. doi:10.5455/JRVS.20230812093455

MLA (The Modern Language Association) Style

APA (American Psychological Association) Style

Durojaye, C. O., Elekofehinti, . O. O., Osho, . I. B. & Abodunrin, . S. O. (2023) Alchornea laxiflora as therapeutic agent in the treatment of Trypanosoma brucei brucei infection using experimental wistar rats; invivo and gene expression studies. Journal of Research in Veterinary Sciences, 1 (1), 27-36. doi:10.5455/JRVS.20230812093455

Author Login Reviewer Login About Publisher Open Access Policy Editorial Policies Editorial Review Policy Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Privacy Policy Corrections, Retractions & Expressions of Concern Self-Archiving Policies Digital Archiving & Preservation Policies Terms of Use License Information Copyright Information

About Journal of Research in Veterinary Sciences

Contact Information

Your comments are very important to us

How to cite this article